semaglutide and multiple sclerosis Ozempic Sclerosis: Insights From Dr. Aaron Boster on GLP-1 Agonists Anti-Myelin Antibodies in Multiple Sclerosis
Description
The use of GLP-1 medications has become a cultural health norm, with more than 12% of Americans having been prescribed them or currently taking them

They mimic the natural GLP-1 hormone, helping people feel fuller, eat less and improve post-meal glucose control (Collins 2024

HSA eligibility for semaglutide injections depends on medical necessity and whether your plan qualifies the medication as a covered preventive or therapeutic benefit

GLP-1 drugs like Ozempic have reshaped conversations around weight loss and metabolic health and skincare brands are now jumping on the trend.

More sustainable